Aspen A Global Supplier And Manufacturer Of Branded And...

Aspen dates back to more than 160 years and they are committed to sustaining life and promoting healthcare through effective and affordable medicine. Aspen is a global supplier and manufacturer of branded and generic pharmaceutical products as well as infant nutritionals and consumer healthcare products in selected territories. Aspen has an extensive global presence and is found in 47 counties all around the world. Aspen has proven themselves over the long run as they continue to increase the number of lives benefitting from their products, reaching more than 150 countries around the world. Aspen’s wide range of products provide treatment to a wide variety of illnesses. Vision: â€Å"To deliver value to all our stakeholders as a responsible corporate citizen that provides quality, affordable medicines and products globally†. Values: Integrity Innovation Excellence Commitment Teamwork Values The commencement of the business in Port Elizabeth 1997- Aspen started trading with Steven Saad and Gus Attridge as two of the four founding members 1998- Aspen was listed on the JSE 1999- Aspen acquired the pharmaceutical business of South African for R2.4 billion rand in a hostile take over 2000- Commenced the building of an oral contraceptive facility at its East London site 2001- Aspen started trading with Australia. Established a clinic in South Africa for disadvantaged people under Aspen’s socio-economic programme. 2002- Aspen concluded a broad-based black economic empowermentShow MoreRelatedGlaxosmithkline18561 Words   |  75 Pagescompany profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures for 2003 (in  £ million)Read MoreGsk Annual Report 2010135604 Words   |  543 PagesAnnual Report 2010 Contents Business review P08–P57 Governance and remuneration P58–P101 Financial statements P102–P191 Shareholder information P192–P212 Business review 2010 Performance overview Research and development Pipeline summary Products, competition and intellectual property Regulation Manufacturing and supply World market GSK sales performance Segment reviews Responsible business Financial review 2010 Financial position and resources Financial review 2009 Risk factors Governance